HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids.

AbstractBACKGROUND:
Keloids are characterized by benign proliferation of fibroblasts in the setting of an altered cytokine profile, with a high recurrence rate after surgical treatment. Imiquimod is a topically applied immune-response modifier. Recently, auxiliary therapy using imiquimod 5% cream to prevent keloid recurrence after excisional surgery was reported to have had good results.
OBJECTIVE:
To evaluate the efficacy of topical imiquimod 5% cream applied after surgical excision and primary closure of trunk keloids in the prevention of recurrence.
METHOD:
Nine patients with a keloid lesion on the trunk were treated with surgical excision and primary closure. Daily application of imiquimod 5% cream for 8 weeks was initiated the night of surgery. The patients were evaluated 2, 4, 8, 12, and 20 weeks after.
RESULTS:
Keloid recurrence occurred in eight patients, seven of them 12 weeks after surgery. We lost track of one patient.
CONCLUSION:
The results of this study suggest that imiquimod 5% cream is not effective in preventing recurrence of trunk keloids after surgical excision. Although this is a small case series, results strongly discourage other studies using imiquimod 5% cream in the prevention of surgically excised trunk keloids.
AuthorsFernanda Marson Cação, Vanessa Tanaka, Maria Cristina de Lourenzo Messina
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 35 Issue 4 Pg. 629-33 (Apr 2009) ISSN: 1524-4725 [Electronic] United States
PMID19415792 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Aminoquinolines
  • Emollients
  • Imiquimod
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Administration, Topical
  • Adult
  • Aminoquinolines (administration & dosage)
  • Emollients
  • Female
  • Humans
  • Imiquimod
  • Keloid (drug therapy, surgery)
  • Male
  • Middle Aged
  • Secondary Prevention
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: